2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

[18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer’s disease

J.B. Rowe, P. Vázquez Rodríguez, Y.T. Hong, R.J. Borchert, S. Sami, W.R. Bevan-Jones, S.P. Jones, R. Arnold, A. Surendranathan, E. Mak, S. Li, T. Fryer, J. O'Brien, L. Passamonti (Cambridge, United Kingdom)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

In vivo evaluation of tau pathologies in patient with progressive supranuclear palsy and healthy subjects with [¹¹C]PBB3-PET

H. Endo, H. Shimada, Y. Kimura, M. Ichise, M. Ono, H. Shinotoh, F. Niwa, S. Kitamura, K. Takahata, S. Hirano, S. Koga, D.W. Dickson, N. Sahara, M. Yamada, M. Higuchi, T. Toda, T. Suhara (Chiba, Japan)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

99mTc-TRODAT-1 SPECT findings in a patient with sporadic Creutzfeldt-Jakob disease

G. Fabiani, S.C.G. Scremin, H.A.G. Teive (Campina Grande do Sul, Brazil)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A case of misdiagnosed Parkinson’s disease (PD)

I. Gabrielyan, K. Harutyunyan, G. Avagyan, H. Amirjanyan, A. Voskanyan, S. Khachaturyan, H. Hambardzumyan, A. Nazaryan, H. Manvelyan (Yerevan, Armenia)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A cognitive fMRI study of non-manifesting LRRK2 and GBA carriers

A. Thaler, N. Bregman, A. Mirelman, T. Gurevich, M. Gana-Weiss, A. Orr-Urtreger, T. Hendler, N. Giladi (Tel-Aviv, Israel)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A comparison of self-report and performance-based balance measures to predict recurrent falls in people with Parkinson’s disease: A cohort study

L.R.S. Almeida, G.T. Valenca, N.N. Negreiros, E.B. Pinto, J. Oliveira-Filho (Salvador, Brazil)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A cross-sectional study in spinocerebellar ataxia type 12 (SCA-12) patients from a tertiary care center in Eastern India

S. Chatterjee, R. Banerjee, B. Mondal, M.U. Kulsum, K. Chatterjee, S.S. Jha, P. Chatterjee, S. Choudhury, S.S. Anand, H. Kumar (Kolkata, India)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A health cost analysis for Huntington disease in Peru

G. Silva-Paredes, M. Cornejo-Olivas, M. Inca-Martinez, K. Espinoza-Huertas, A. Vishnevetsky, P. Mazzetti, R. Urbanos-Garrido (Lima, Peru)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A largest case series study of spinocerebellar ataxia type 2(SCA2) from India: Do SCA2 clinical subtypes exists?

A.K. Srivastava, A.K. Sonakar, S. Shakya, V. Suroliya, A. Takkar, I. Ahmad, R.K. Singh, I. Singh, D. Vibha, G. Shukla, V. Goyal, K. Prasad, A. Garg, M. Faruq (New Delhi, India)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease

J. Wang, Z. Mosher, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2